Suxiao Jiuxin Pill attenuates acute myocardial ischemia via regulation of coronary artery tone

Suxiao Jiuxin Pill (SJP) is a well-known traditional Chinese medicine drug used to manage heart diseases. This study aimed at determining the pharmacological effects of SJP in acute myocardial infarction (AMI), and the molecular pathways its active compounds target to induce coronary artery vasorela...

Full description

Saved in:
Bibliographic Details
Main Authors: Sa Li (Author), Jiaguo Zhan (Author), Yucheng Wang (Author), Patrick Kwabena Oduro (Author), Felix Boahen Owusu (Author), Jiale Zhang (Author), Ling Leng (Author), Ruiqiao Li (Author), Shujie Wei (Author), Jun He (Author), Qilong Wang (Author)
Format: Book
Published: Frontiers Media S.A., 2023-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ff899674a08b4c1c94964d0acdedbd07
042 |a dc 
100 1 0 |a Sa Li  |e author 
700 1 0 |a Jiaguo Zhan  |e author 
700 1 0 |a Yucheng Wang  |e author 
700 1 0 |a Patrick Kwabena Oduro  |e author 
700 1 0 |a Felix Boahen Owusu  |e author 
700 1 0 |a Jiale Zhang  |e author 
700 1 0 |a Ling Leng  |e author 
700 1 0 |a Ling Leng  |e author 
700 1 0 |a Ruiqiao Li  |e author 
700 1 0 |a Ruiqiao Li  |e author 
700 1 0 |a Shujie Wei  |e author 
700 1 0 |a Jun He  |e author 
700 1 0 |a Jun He  |e author 
700 1 0 |a Qilong Wang  |e author 
700 1 0 |a Qilong Wang  |e author 
700 1 0 |a Qilong Wang  |e author 
700 1 0 |a Qilong Wang  |e author 
245 0 0 |a Suxiao Jiuxin Pill attenuates acute myocardial ischemia via regulation of coronary artery tone 
260 |b Frontiers Media S.A.,   |c 2023-05-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2023.1104243 
520 |a Suxiao Jiuxin Pill (SJP) is a well-known traditional Chinese medicine drug used to manage heart diseases. This study aimed at determining the pharmacological effects of SJP in acute myocardial infarction (AMI), and the molecular pathways its active compounds target to induce coronary artery vasorelaxation. Using the AMI rat model, SJP improved cardiac function and elevated ST segment. LC-MS and GC-MS detected twenty-eight non-volatile compounds and eleven volatile compounds in sera from SJP-treated rats. Network pharmacology analysis revealed eNOS and PTGS2 as the key drug targets. Indeed, SJP induced coronary artery relaxation via activation of the eNOS-NO pathway. Several of SJP's main compounds, like senkyunolide A, scopoletin, and borneol, caused concentration-dependent coronary artery relaxation. Senkyunolide A and scopoletin increased eNOS and Akt phosphorylation in human umbilical vein endothelial cells (HUVECs). Molecular docking and surface plasmon resonance (SPR) revealed an interaction between senkynolide A/scopoletin and Akt. Vasodilation caused by senkyunolide A and scopoletin was inhibited by uprosertib (Akt inhibitor) and eNOS/sGC/PKG axis inhibitors. This suggests that senkyunolide A and scopoletin relax coronary arteries through the Akt-eNOS-NO pathway. In addition, borneol induced endothelium-independent vasorelaxation of the coronary artery. The Kv channel inhibitor 4-AP, KCa2+ inhibitor TEA, and Kir inhibitor BaCl2 significantly inhibited the vasorelaxant effect of borneol in the coronary artery. In conclusion, the results show that Suxiao Jiuxin Pill protects the heart against acute myocardial infarction. 
546 |a EN 
690 |a Suxiao Jiuxin Pill 
690 |a senkyunolide a 
690 |a scopoletin 
690 |a borneol 
690 |a vasorelaxation 
690 |a acute myocardial infarction 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 14 (2023) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2023.1104243/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/ff899674a08b4c1c94964d0acdedbd07  |z Connect to this object online.